{"nct_id":"NCT00851890","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection","status":"COMPLETED","status_verified_date":"2014-12","start_date":"2009-03","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}